Related Experiment Video
Updated: Jul 9, 2026

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
Published on: August 6, 2014
A comparative study on the genotoxic effect of pyrimethamine in bone marrow and spermatogonial mice cells
Scrap Celikler1, Nilüfer Aydemir, Rahmi Bilaloğlu
1Uludag University, Science and Arts Faculty, Biology Department, 16059 Görükle, Bursa, Turkey. scelikler@uludag.edu.tr
Abstract:
Pyrimethamine is an antimalarial agent widely used in clinical therapy. We aimed to compare its mutagenic potential in mammalian spermatogonial and bone marrow cells. For studying chromosomal aberrations mice were treated acutely (single treatment) with 4 dose levels of pyrimethamine (5, 10, 20 and 40 mg/kg). Pyrimethamine was found to produce a significant increase in structural chromosomal aberrations after acute treatment in bone marrow cells of mice (p < 0.001). It also induced chromosome abnormalities in spermatogonial cells (p < 0.05) at the highest dose.
Insights
Pyrimethamine, an antimalarial drug, showed mutagenic potential by significantly increasing chromosomal aberrations in mouse bone marrow cells. It also induced abnormalities in spermatogonial cells at higher doses.
Area of Science:
- Toxicology
- Genetics
- Pharmacology
Background:
- Pyrimethamine is a widely used antimalarial drug in clinical settings.
- Assessing the mutagenic potential of pharmaceuticals is crucial for patient safety.
Purpose of the Study:
- To compare the mutagenic effects of pyrimethamine in mammalian spermatogonial and bone marrow cells.
- To evaluate chromosomal aberrations induced by pyrimethamine treatment.
Main Methods:
- Mice were administered single acute doses of pyrimethamine at 5, 10, 20, and 40 mg/kg.
- Structural chromosomal aberrations were analyzed in bone marrow and spermatogonial cells.
Main Results:
- Pyrimethamine significantly increased structural chromosomal aberrations in mouse bone marrow cells (p < 0.001).
- Chromosome abnormalities were also observed in spermatogonial cells, particularly at the highest dose (p < 0.05).
Conclusions:
- Pyrimethamine exhibits mutagenic potential in mammalian somatic and germ cells.
- These findings highlight the importance of monitoring for genotoxicity during antimalarial therapy.
More Related Videos
09:40A Seminiferous Tubule Squash Technique for the Cytological Analysis of Spermatogenesis Using the Mouse Model
Published on: February 6, 2018
11:24Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
Published on: July 3, 2015